Decision-making for people with dementia and advanced kidney disease: a secondary qualitative analysis of interviews from the Conservative Kidney Management Assessment of Practice Patterns Study. by Scott, Jemima et al.
1Scott J, et al. BMJ Open 2018;8:e022385. doi:10.1136/bmjopen-2018-022385
Open access 
Decision-making for people with 
dementia and advanced kidney disease: 
a secondary qualitative analysis of 
interviews from the Conservative 
Kidney Management Assessment of 
Practice Patterns Study
Jemima Scott,1,2 Amanda Owen-Smith,2 Sarah Tonkin-Crine,3 Hugh Rayner,4 
Paul Roderick,5 Ikumi Okamoto,5 Geraldine Leydon,5 Fergus Caskey,1,2,6 
Shona Methven6,7
To cite: Scott J, Owen-
Smith A, Tonkin-Crine S, et al.  
Decision-making for people 
with dementia and advanced 
kidney disease: a secondary 
qualitative analysis of interviews 
from the Conservative 
Kidney Management 
Assessment of Practice 
Patterns Study. BMJ Open 
2018;8:e022385. doi:10.1136/
bmjopen-2018-022385
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
022385). 
Received 15 February 2018
Revised 26 July 2018
Accepted 28 September 2018
For numbered affiliations see 
end of article.
Correspondence to
Dr Jemima Scott;  
 jemimascott@ doctors. org. uk
Research
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Objective To explore dialysis decision-making for adults 
who lack capacity due to cognitive impairment, a common 
and under-recognised condition in those with advanced 
chronic kidney disease (CKD).
Design Secondary analysis of qualitative data collected 
during the Conservative Kidney Management Assessment 
of Practice Patterns Study programme of research 
was performed. Sixty semistructured interviews were 
conducted with multiprofessional team members from UK 
renal centres. Staff were asked about local facilities, the 
value of conservative kidney management (CKM), when 
and with whom CKM was discussed and how CKM could 
be improved. Thematic analysis was employed to identify, 
characterise and report on themes that emerged from the 
data, focused on the specific issues experienced by people 
with dementia.
setting A purposive sample of nine UK renal centres 
differing in the scale of their CKM programmes.
Participants Clinical directors of renal centres identified 
staff involved in CKM. Staff were asked to participate if 
they had experience of low clearance clinics or of caring 
for patients with advanced CKD (estimated glomerular 
filtration rate <20mL/min/1.732 or >65 years with end-
stage kidney disease).
results Two overarching themes were identified: factors 
taken into consideration during decision-making, and 
the process of decision-making itself. Comorbidity, social 
support, quality of life and the feasibility of dialysis were 
reported as factors pertinent to clinicians’ decisions 
regarding suitability. The majority of renal centres 
practised multidisciplinary ‘best interests’ decision-making 
for those without capacity. Attitudes to advance care 
planning were divided.
Conclusions In view of the prevalence of cognitive 
impairment among those with advanced CKD, we suggest 
consideration of routine assessment of cognition and 
capacity. In the UK, dialysis is initiated and continued for 
individuals with dementia and services should be adapted 
to meet the needs of this population.
IntrODuCtIOn 
Dementia is characterised by a decline in one 
or more cognitive domains, severe enough 
to interfere with activities of daily living 
(ADLs).1 Mild cognitive impairment (MCI) 
may be a precursor to dementia, in which 
impaired cognition exists but is insufficient 
to effect independence or ADLs.2 A 2009 
meta-analysis of Mayo-defined MCI showed 
progression to dementia in 32.3% (95% CI 
17.9% to 48.5%) over a mean 4.6 years (SD 
2.14).3 
Chronic kidney disease (CKD) is an inde-
pendent risk factor for cognitive impairment.4 
Its prevalence in those with CKD is widely 
under-recognised.5 6 A prospective cohort 
study found 61% of those with CKD4-5 had 
a Mini-Mental State Exam (MMSE) score ≤24 
at baseline, indicative of significant impair-
ment.7 Orientation–attention and language 
skills are predominantly affected which may 
specifically impact on an individual’s ability to 
strengths and limitations of this study
 ► This is the first qualitative analysis of this size to 
assess the opinions of renal healthcare profession-
als regarding the management of end-stage kidney 
disease for people with dementia.
 ► Purposive sampling of renal units and the breadth of 
professionals involved in these interviews provided 
granular data for study.
 ► This is a secondary analysis of data collected for 
an alternative purpose: lack of specific questions 
regarding patients with dementia limited the scope 
of investigation with respect to our specific research 
question.
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engage with healthcare decisions.8 In a qualitative study 
of patients with Alzheimer’s disease and their carers, 
patient involvement in medical decision-making declined 
significantly once the MMSE score fell below 20.9 The UK 
Renal Association recommends that ‘most patients whose 
eGFR is <30 mL/min/1.73m2 and declining should 
receive timely and personalised information regarding 
established kidney failure and renal replacement therapy 
options so they can make an informed decision about 
treatment’.10 Given the complexity of decision-making 
regarding renal replacement therapy (RRT), those with 
cognitive impairment struggle without support and some 
will lack capacity.
There are multiple treatment options for end-stage 
kidney disease (ESKD): haemodialysis (in a healthcare 
setting or at home), peritoneal dialysis (at home, performed 
by the patient or an informal carer) including assisted 
automated peritoneal dialysis (assisted APD) (supported 
by daily staff visits) or conservative kidney management 
(CKM) (supportive treatment and symptom control). 
There is a growing appreciation of CKM as an alternative 
to dialysis for older patients with multimorbidity and poor 
prognosis,11–13 but a lack of consensus on how to identify 
this group. In a recent survey of UK renal centres, all but 
one reported having an ‘alternative to dialysis’ pathway; 
however, the percentage of patients over 75 years managed 
on this pathway varied from less than 10% to 40%–50%.14 
Renal transplantation is rarely appropriate for people with 
dementia due to the progressive nature of the disorder 
and associated comorbidity. ESKD decision-making is 
clinically challenging, emotive and preference sensitive. 
Relative benefits and disadvantages of treatment options 
differ between patients as variation in physical health and 
patients’ values15 16 influence the trade-off between quality 
versus quantity of life. Guidelines based purely on clinical 
trial data risk conflict with patient-centred care unless pref-
erence sensitivity is accounted for.17
In the UK, USA and Europe, four legal standards must 
be met to demonstrate capacitous decision-making: (1) 
to understand information given regarding the proposed 
treatment and expected risks and benefits, (2) to retain this 
information for sufficient time to reach a decision, (3) to 
be able to weigh up the advantages and disadvantages and 
(4) to communicate a decision.18–20 Several models of deci-
sion-making have been described for those lacking capacity: 
advance decisions, substituted judgement and best inter-
ests. Advance care plans (ACP) enable the individual to 
refuse future treatment, although not to demand care.21 
Substituted judgement attempts to replicate the choice an 
individual would have made, had he been capacitous. This 
is frequently used in the USA.22 In the UK, the majority of 
such decisions use the ‘best interests’ of the patient, as set 
out in the Mental Capacity Act 2005. In this model, surro-
gate decision-makers, carers and professionals choose what 
they believe to be the best action at the current time and in 
the future.22
The doctor–patient relationship has evolved and there 
is now an expectation that the patient should make, or 
at least have significant input into, medical decisions.23 24 
However, as dementia progresses, the degree of input the 
individual has into any given decision diminishes and, 
over time,9 many lose capacity to make competent deci-
sions regarding health and medical care. The degree of 
autonomy is dependent on the question being asked as 
well as individual characteristics of patient and clinician. 
Jayanti et al demonstrated that older patients were less 
likely to want active involvement in decision-making.25 
Other predictors of low engagement included high 
comorbidity score, poor executive brain function and 
lack of functional independence.25
This study contributes to our understanding of how 
decisions regarding dialysis versus CKM are made for 
patients with cognitive impairment who lack capacity.
MethODs
Design and setting
This study reports a secondary analysis of qualitative data 
collected by the Conservative Kidney Management Assess-
ment of Practice Patterns Study (CKMAPPS) programme 
of research (see online supplementary appendix 1), 
conducted in England 2011–2013. CKMAPPS was 
designed to determine current UK practice patterns 
for CKM and to inform service development and future 
research. The programme comprised three qualitative 
and one quantitative study. Purposive sampling was used 
to identify nine renal centres across the UK differing in 
the scale of their CKM programmes. Within these centres, 
semistructured interviews were conducted with members 
of the renal multiprofessional team (see ‘Participants’ for 
details of sampling strategy). A favourable ethical opinion 
was obtained from South Birmingham National Research 
Ethics Committee (11/WM/0240). The original analysis 
is reported elsewhere.14
sampling
Clinical directors of renal centres identified staff involved 
in CKM. Staff were asked to participate if they had expe-
rience of low clearance clinics or of caring for patients 
with advanced CKD (estimated glomerular filtration 
rate <20mL/min/1.732 or >65 years with ESKD). A 
minimum of one consultant nephrologist and one staff 
nurse were recruited from each unit.
Interviews
Prior written consent was obtained from all participants. 
Semistructured interviews were conducted face to face 
or by telephone. There was no pre-existing relationship 
between the participants and the interviewers, who were 
experienced qualitative researchers from the University of 
Southampton. The interview schedule (see online supple-
mentary appendix 2) was designed using a prior literature 
review and input from steering committee members, and 
adapted using an iterative process as participants intro-
duced new topics. Staff were asked about how CKM was 
delivered, the role of primary and palliative care services, 
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their views on CKM and experiences of involvement in 
CKM decision-making. Interviews were audio-recorded 
digitally and transcribed verbatim.
Data analysis
A secondary thematic analysis was conducted to iden-
tify themes within interviews with relevance to deci-
sion-making for adults who lack capacity as a result of 
cognitive impairment. NVivo V.10 qualitative data anal-
ysis software (QSR International) was used to facilitate 
coding. Each transcript was read by one of two clinical 
researchers, JS and SM, who were not involved in the orig-
inal data collection process. Codes attached to the text 
highlighted significance with regards to the study ques-
tion. Eight interviews were coded independently by both 
researchers to check consistency in the identification of 
relevant themes. Differences were resolved by discussion. 
Consensus was reached on an initial coding framework 
and applied to the remainder of the transcripts (divided 
between the two researchers). Saturation of themes 
related to cognitive impairment was achieved within this 
secondary analysis; however, this was not an explicit objec-
tive of data collection.
The initial framework was further developed through 
an iterative process as data analysis continued. Individual 
codes were built into a thematic framework, which was 
used to structure the analysis reported in this article. 
Particular attention was paid where there were differences 
in views expressed between interviewees, which were used 
as a platform for further in-depth analysis.
Patient involvement
The original CKMAPPS programme of the study was 
planned in collaboration with Kidney Alliance, a body that 
aims to bring together the patients’ voice and professionals 
committed to renal medicine. The Chair of Kidney Alliance 
was part of the research team. Through this organisation, 
patients were involved in informing the study design and 
outcomes, as well as drafting patient information resources. 
Patients were not directly involved in recruitment. The 
results of the original CKMAPPS study were shared with 
patients via the Chair of Kidney Alliance.
results
Sixty staff interviews were undertaken in the initial 
CKMAPPS study (six to nine per unit). Participants 
included 22 nephrologists, 25 nurses, one palliative care 
consultant and 12 allied health professionals (six social 
workers, three dieticians, two counsellors, one pharma-
cist). Forty-seven participants were women. Median age 
was 49 years (range 28–67). Forty-seven participants 
described their ethnicity as White–British, five as White–
Other, three as Asian British–Indian, two as Asian–Indian, 
one Asian–Other Asian, one Asian, one Mixed White and 
Asian and one as Fijian.
Fifty-nine interviews were included in this secondary 
analysis (one interview with a renal information 
technology systems manager was not transcribed). Two 
overarching themes were identified: factors taken into 
consideration during decision-making, and the process 
of decision-making itself. Several minor themes emerged 
within each core concept and are numbered below, with 
illustrative quotations.
FACtOrs tAken IntO COnsIDerAtIOn DurIng DIAlysIs 
DeCIsIOn-MAkIng
Comorbidity and prognosis
CKM was most frequently considered for individuals 
with multimorbidity, especially for those with dementia, 
cardiac disease or malignancy, due to lack of symptomatic 
and survival benefit.
For patients who are over 75, who have got lots of 
illnesses… dialysis isn’t guaranteed to make them live 
longer or feel better….those patients who have got a 
number of co-morbidities, so patients who have got 
heart failure, COPD, dementia… conservative man-
agement is very, very appropriate.(Specialist Nurse, 
Unit 8)
However, one nurse commented that the patient’s 
psychological state was more important than their phys-
ical health with regards to the tolerability and success of 
dialysis.
I think a lot of elderly [person] people …they have 
a zest for life and however physically immobile they 
are, they still do incredibly well because it’s about 
your psyche and your capacity to cope with dialysis as 
opposed to your physical ability to cope with it. (Staff 
Nurse, Unit 5)
Some staff suggested that cognitive impairment might 
negatively impact on the success of RRT, while dialysis 
itself might accelerate mental decline.
I suppose the classic thing [in the CKM clinic] is 
there are often very significant vascular [paths], am-
putations, heart attacks, strokes—and they sometimes 
have a significant element of cognitive decline—
and I know that that may well get worse on dialysis. 
(Consultant Nephrologist, Unit 8)
the feasibility of dialysis
Clinicians commented on the feasibility of dialysis. 
Physical and psychological health problems were seen 
as potential barriers to successful RRT. Some clinicians 
advocated a trial of dialysis, with cessation of treatment if 
the patient exhibited distress or the staff or patient were 
put at risk by the patient’s behaviour.
It’s not only [difficult] for them [patients with de-
mentia]; it’s difficult to look after them. To dialyse 
them is pretty hard.’ (Consultant Nephrologist,  
Unit 1)
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Despite this, several participants reported that it was 
not uncommon for patients with dementia to be started 
on dialysis; good outcomes were noted for some.
Some of the patients who don’t have capacity per-
haps, who we have best interest meetings and then 
the decision is for the patient actually to have dial-
ysis, and it…has worked really well. (Social Worker,  
Unit 3)
Assisted APD and CKM were proposed as alternative 
options for those unable to tolerate haemodialysis. Staff 
suggested the extra support received with assisted APD 
could overcome the challenge of ensuring a patient was 
physically and cognitively able to manage the technique.
We’ve got our own assisted APD programme as well 
so that’s helped quite a lot with patients that perhaps 
can’t cope with dialysis themselves or can’t cope with 
coming in and out for [haemo]dialysis. (Staff Nurse, 
Unit 3)
Quality of life
Many staff reported taking into account a patient’s quality 
of life (QoL), specifically considering cognitive impair-
ment, when considering suitability for RRT. Clinicians 
recognised deterioration in the QoL in patients receiving 
haemodialysis; many felt this was reason to avoid dialysis 
in those with poor QoL at baseline.
I’ve got an old lady um, who lives in the nursing home, 
her husband has got dementia, she has got an ele-
ment of dementia too, and she is having four hours of 
dialysis every other day. and she is bed bound, she is 
stretchered in, stretchered out, hoisted…what quality 
of life have we? (Staff Nurse, Unit 6)
The increased time spent in hospital as well as travel-
ling to and from dialysis was believed to be particularly 
detrimental to QoL.
Sometimes the [more] frailer people, if they are on 
dialysis, end up having more hospital admissions: just 
things like the burden of travelling backwards and for-
wards to the dialysis unit. (Consultant Nephrologist, 
Unit 7)
the provision of services for eskD
Clinicians suggested that where there was a lack of assisted 
APD, frail patients were more likely to receive CKM.
Those patients [receiving assisted APD] would have 
[otherwise] been for non-dialysis care in many senses 
because haemodialysis would have been too distress-
ful. (Matron, Unit 3)
While underprovision in one modality was felt to 
discourage referrals, clinicians felt that good local services 
actively encouraged referral for that pathway.
Because we have got an active conservative man-
agement programme my colleagues feel you know 
although the patient is elderly we can still offer them 
something. …You feel that you can do something 
proactive. (Consultant Nephrologist, Unit 1)
However, a nurse expressed concerns that patients may 
feel pressured into accepting a specific dialysis modality 
solely because of availability.
Because there is an option to use assisted APD, there’s 
a chance and a risk that it would be used inappropri-
ately…to just attach someone to a machine because 
the opportunity is there, I don’t feel is appropriate. 
(PD Nurse, Unit 4)
Clinicians’ perceptions of social support
Good family support was seen by many as key to the success 
of dialysis for those with dementia, but also important in 
the delivery of good quality CKM. Clinicians expressed 
uncertainty as to which modality was preferable in those 
without such support networks.
It is more difficult to keep people well on dialysis 
treatment if they have poor social support but it is 
also more difficult to maintain a good quality of life 
for them with conservative management. (Consultant 
Nephrologist, Unit 5)
Some nursing staff felt that family support was of 
greater importance to dialysis success than age or clinical 
condition. Doctors were more likely to mention clinical 
factors and longevity.
We offer dialysis to everybody….just because they’ve 
got a learning disability or a little bit of dementia, if 
they are pleasantly confused and coping and good 
family support, they can have it. (Education Nurse, 
Unit 9)
Staff recognised the potential for both dialysis and 
CKM to offer social support to patients and their families. 
The CKM specialist nurse was described as a pivotal link 
between medical and social services.
If they’d (CKM patients) like a bit more help, we 
can get the district nurses to do an assessment…
you can…get the Macmillan nurses involved. (CKM 
Specialist Nurse, Unit 6)
In addition, dialysis was suggested to provide respite for 
carers.
I’ve had one or two cases where they [carers] don’t 
want them [patients] at home, they would rather 
pack them off for haemodialysis… It just gives them 
the opportunity to have a bit of a rest. (Staff Nurse, 
Unit 6)
PrOCesses InvOlveD In DIAlysIs DeCIsIOn-MAkIng
ethico-legal aspects of decision-making
Participants discussed ethical and legal implications of 
making dialysis decisions for patients lacking capacity. 
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Some suggested that the complexity of information 
relating to RRT may limit the numbers of patients able 
to make capacitous decisions regarding the management 
of ESKD.
For some patients, particularly the elderly, who are 
really starting to experience vascular problems—and 
have an element of vascular cognitive impairment, 
just understanding anything about renal failure or 
anything about what’s happening to them, is so com-
plicated. (Consultant Nephrologist, Unit 8)
The legal framework of best interests decision-making 
was used in cases where it was deemed that the patient 
lacked capacity.
We will make the decision on their behalf [for pa-
tients with severe cognitive impairment] and then 
we will say patient’s best interest or medical decision. 
(Consultant Nephrologist, Unit 1)
Participants from five units reported being involved 
in regular multidisciplinary best interests meetings, 
involving clinicians, social workers and often the general 
practitioner, while others did not.
We don’t have a discussion forum where we…or 
a multidisciplinary meeting where we discuss pa-
tients with these decisions [r/e RRT]. (Consultant 
Nephrologist, Unit 5)
In these centres, the individual consultant appeared to 
have the greatest influence on choice of dialysis modality.
Ultimately it [dialysis decision] comes down to the 
Consultant, really, that’s looking after the patient. 
(Staff Nurse, Unit 2)
The majority of staff preferred family members to be in 
agreement with the decision made.
If a person has got some degree of dementia [they 
would be appropriate for CKM] ….we’d always try to 
involve the family….not just the doctors we’d try and 
involve the family agreeing with that decision [for 
CKM]. (Staff Nurse, Unit 3)
Staff commonly believed that families tended to wish 
for aggressive treatment of their relative, due to a lack of 
appreciation of the rigours of dialysis, unrealistic expecta-
tions and unwillingness to accept mortality.
I get patients with mobility problems and demen-
tia problems and vascular problems and their rela-
tives….believe that dialysis will cure all of the above. 
(Consultant Nephrologist, Unit 8)
One consultant commented on the Lasting Power of 
Attorney, and the challenge of ensuring that they are 
truly acting in the patient’s best interests.
What is very difficult is to have a patient without ca-
pacity, somebody with Power of Attorney for their 
health needs and that person making decisions that 
are not, in our view, in the interests of the patient. 
(Consultant Nephrologist, Unit 7)
the role of advance care planning
There was significant disparity between both units and 
individual clinicians regarding the benefits and disadvan-
tages of ACPs. Some argued that ACPs avoided the need 
to make hasty decisions and afforded adequate time to 
prepare the patient both physically and psychologically 
for the chosen treatment modality. ACPs were described 
as particularly advantageous in the context of declining 
cognition.
You can head that situation off [best interests decision 
making] by having advanced discussions when the 
patient has full capacity. (Consultant Nephrologist, 
Unit 7).
Others believed early decision-making was inappro-
priate. Reasons given included avoiding unnecessary 
distress should the patient never reach ESKD, the inability 
of patients to anticipate how they may feel in the future 
and the possibility of a change in health status such that 
an earlier decision is rendered inappropriate.
One [patient] had a little bit of dementia but she was 
very, very pleasant and was great coming to clinic … 
she was all ready … [but] round the time she started 
dialysis—she had just got a little bit more confused…. 
didn’t do well, didn’t want it, was very confused, 
kept wanting to pull to pull her dialysis needles out, 
screamed—you know—just didn’ t cope. (Education 
Nurse, Unit 9)
DIsCussIOn
In this secondary analysis of CKMAPPS, interviews with 
renal centre staff were analysed to understand the deci-
sion-making processes regarding ESKD management for 
patients with cognitive impairment who lack capacity. 
Participants reported using the framework of best inter-
ests decision-making and were divided as to their appre-
ciation of ACPs. In the initial CKMAPPS survey of 67 UK 
renal units, 87.9% held regular multidisciplinary team 
meetings for difficult RRT decisions; however, in these 
interviews, staff from several centres suggested that the 
primary decision-maker was the individual consultant. 
Key influences on these decisions included comorbidity, 
the feasibility of dialysis and the clinician’s perception 
of the patient’s QoL and social care. Individual consul-
tant preference and the local provision of services also 
impacted on the outcome. CKM was generally thought to 
be the most appropriate option for patients with cogni-
tive impairment who lack capacity. Nevertheless, several 
reports emerged of such patients being commenced on 
dialysis.
The UK Mental Capacity Act 2005 states that a Best 
Interests Meeting involves ‘the considered input of a 
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number of different staff as well as those with a personal 
and/or legal interest in the needs of the person lacking 
mental capacity….(and takes) into consideration all rele-
vant circumstances, including the person’s beliefs and 
values, past and present wishes, and any written state-
ments the person made when she/he had capacity’.26 
Participants in this study were generally unwilling to 
make best interests decisions regarding dialysis without 
the family’s agreement; however, some expressed doubt 
regarding the ability of relatives to act as reliable surro-
gate decision-makers. Similar concerns have been raised 
previously.27–30 Markes and Arkes31 found that next 
of kin based decisions on what they themselves would 
have wanted, rather than reflecting the patient’s wishes. 
Discordance widened between patient and surrogate 
decision-maker where the patient’s preference was to 
refuse treatment.32 In this study, some clinicians believed 
ACPs might overcome these difficulties, although those 
in opposition suggested early RRT discussions might 
cause unnecessary distress for individuals who would 
never reach ESKD.33 Such concerns are challenged by a 
study of patients recently diagnosed with dementia, which 
showed overwhelmingly positive results from ACPs for 
both patient and caregiver.34 ACP is a core component of 
the Department of Health for England’s End of Life Care 
Strategy,35 and has been shown to increase QoL, reduce 
hospitalisations and increase home deaths.36 ACPs may 
be of particular benefit to those with progressive cogni-
tive impairment where deterioration in decision-making 
capability may be anticipated. Despite this, less than 20% 
of patients with dementia are believed to have an ACP in 
the UK.37
This analysis raises issues of relevance to current clin-
ical practice. First, given the prevalence of cognitive 
impairment in those with advanced CKD, the introduc-
tion of regular assessments of cognition and capacity into 
routine clinical practice should be considered. Screening 
tools such as the Montreal Cognitive Assessment and the 
Mini-Addenbrookes Cognitive Examination have been 
validated for both dialysis and CKD patients.38 39 Iden-
tification of early cognitive impairment may prompt 
clinicians to initiate ACPs before loss of decision-making 
capability. ACPs should be regularly revisited to ensure 
that treatment preferences remain appropriate in the 
presence of changing comorbidity, cognitive function 
and QoL.
Second, there is a pressing need for the development 
of ESKD services (CKM, peritoneal and haemodialysis) 
which meet the needs of those with dementia. Given 
the rise in average age at dialysis initiation in the UK, 
the clustering of cardiovascular risk factors leading to 
ESKD and dementia and the growing burden of comor-
bidity for those living to ever greater ages, the coexis-
tence of dementia in those receiving dialysis will almost 
certainly rise. This is in contrast to the overall plateau 
in dementia prevalence seen in the UK in recent years. 
The additional staff training, costs and time required to 
develop such programmes may be difficult to achieve 
in the face of increasing financial pressures within 
healthcare.
This study is the first qualitative analysis of this scale 
to assess the opinions of renal healthcare professionals 
regarding ESKD management for patients with cognitive 
impairment, a growing concern in the ageing population. 
Purposive sampling of renal centres and the breadth of 
professionals involved in these interviews should allow 
transferability of results to other UK renal centres. Despite 
this, limitations are recognised. This secondary analysis of 
interview data was collected for an alternative purpose, 
assessing attitudes to delivery of CKM. Lack of specific 
questions regarding patients with cognitive impairment 
will limit the potential richness of the data collected with 
regards to our specific research question.
Further research is required to determine the accept-
ability of screening for cognitive impairment in the 
advanced CKD population, the frequency of screening 
required and whether formal diagnosis changes manage-
ment. Thought should also be given to potential disad-
vantages of diagnosis. It is important to investigate the 
attitudes of those with cognitive impairment to ACP 
with regard to RRT, whether attitudes change with 
disease progression and if care plans hold weight when 
individuals reach ESKD. Understanding the impact of 
different ESKD management modalities on QoL of those 
with cognitive impairment will influence future service 
development.
COnClusIOns
This secondary analysis of the CKMAPPS advances our 
understanding of dialysis decision-making for patients 
with cognitive impairment who lack capacity. Comor-
bidity, social support, QoL and the feasibility of dialysis 
were reported as factors pertinent to clinicians’ deci-
sions regarding suitability. The majority of renal centres 
practised multidisciplinary team ‘best interests’ deci-
sion-making and were unwilling to act against the wishes 
of relatives. Attitudes to ACP, which may offer particular 
benefit to those with progressive cognitive impairment, 
were divided. We suggest that in view of the prevalence of 
cognitive impairment among those with advanced CKD, 
the benefits and disadvantages of routine assessment of 
cognition and capacity for these individuals should be 
determined and consideration made to integration of 
such assessments into routine clinical practice. In the UK, 
dialysis is both initiated and continued for individuals 
with dementia and services should be adapted to meet 
the needs of this population.
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